FDA: Succinylcholine No Longer in Short Supply

The Food and Drug Administration Drug Shortage Division has reported that two companies, Hospira and Sandoz, are producing succinylcholine injections, according to an ASA report.

Advertisement

Succinylcholine is a paralytic drug used to induce muscle relaxation and short-term paralysis, usually to facilitate tracheal intubation. The two manufacturers are now able to manufacture enough succinylcholine to meet market demands.

This is a positive development for patients and physicians, considering an April 2011 ASA survey on drug shortages found that 47.6 percent of respondents were experiencing a shortage of succinylcholine.

Read the ASA release on succinylcholine.

Related Articles on Anesthesia:
Anesthesiologist Dr. Marshall Joins Joins North Dakota’s Medcenter One
Florida Anesthesiologists Launch National Consulting Firm
Pennsylvania Anesthesiologist Pleads Guilty to Tax Case in Federal Court

Advertisement

Next Up in Anesthesia

Advertisement

Comments are closed.